Abstract Understanding the interaction of the atherogenic lipoprotein, lipoprotein(a) [Lp(a)], with macrophages may provide important insight into the physiology and pathophysiology of this lipoprotein. We have recently shown that cholesterol loading of macrophages, such as occurs in atheroma foam cells, leads to marked upregulation of a novel receptor activity for native Lp(a) and its plasminogen-like protein component, apoprotein(a) [apo(a)]. We show here that the Lp(a)/apo(a) receptor activity on cholesterol-loaded macrophages is trypsin sensitive, indicating that a cell-surface protein is involved and that the upregulation by cholesterol loading requires new protein synthesis. Ligand studies revealed that the foam cell receptor activity recognizes Lp(a) containing both small and large isoforms of apo(a) as well as rhesus monkey Lp(a), which contains an inactive kringle-4 37 (K4 37 ) lysine-binding domain. Elastase degradation products of plasminogen did not compete for 12 Elevated plasma levels of Lp(a) occur in «=20% of the adult Caucasian population, and there appears to be an association between elevated Lp(a) levels and the occurrence of coronary atherosclerosis.
I-labeled recombinant apo(a) [
125 I-r-apo(a)] internalization and degradation by foam cells, indicating that the K4 37 sequence, as well as the K5 and "protease" domains of apo(a), are not sufficient for receptor L ipoprotein(a) [Lp(a)] is a lipoprotein consisting of a low-density lipoprotein (LDL) particle covalently attached to a plasminogen-like glycoprotein, apoprotein(a) [apo(a)]. 12 Elevated plasma levels of Lp(a) occur in «=20% of the adult Caucasian population, and there appears to be an association between elevated Lp(a) levels and the occurrence of coronary atherosclerosis.
1 -2 Furthermore, cholesterolfed apo(a) transgenic mice develop significantly more atherosclerosis than nontransgenic controls. 3 Despite several important hypotheses and in vitro observations regarding possible roles of Lp(a) in atherosclerosis, 47 neither the mechanism of Lp(a) atherogenicity nor the normal physiological roles of the lipoprotein are definitively known. Nonetheless, the interaction of Lp(a) with macrophages is thought to be important, since cholesteryl ester-filled macrophages (foam cells) are a prominent feature of atherosclerotic lesions. 810 In fact, apo(a) has been found to colocalize with foam cells in these lesions. 11 interaction. Consistent with these data, the degradation of 125 I-r-apo(a) was completely blocked by an anti-Lp(a) polyclonal antibody that does not cross-react with plasminogen. Furthermore, the multiple sialic residues of apo(a) are also not involved in receptor interaction, since desialylated r-apo(a) interacted with foam cells as well as native r-apo(a). In contrast, reduced and denatured r-apo(a) was degraded by foam cells only slightly better than by control cells [28% increased degradation by foam cells versus 450% for native r-apo(a)], suggesting that the upregulated receptor activity recognizes certain secondary and tertiary structural features of apo(a). In summary, foam cells mediate the internalization and degradation of Lp(a) and apo(a) by a cell-surface receptor activity whose induction by cholesterol loading requires new protein synthesis. Remarkably, this receptor activity recognizes features of apo(a) that are distinct from those of plasminogen despite an 80% homology between these two proteins. Previous studies have shown that cultured macrophages internalize and degrade native Lp(a) and apo(a) poorly. 1215 Recent work from our laboratory, however, revealed an Lp(a) receptor activity, different from known lipoprotein receptors, that can be induced in macrophages by cholesterol loading. 16 The interaction of Lp(a) with cholesterol-loaded macrophages is solely dependent on the apo(a) moiety of Lp(a), since lipid-free recombinant apo(a) [r-apo(a)] but not apo(a)-free Lp(a-) is recognized by the foam cell receptor activity. 16 In the present study, we investigated whether a cell-surface protein is involved in the foam cell Lp(a)/ apo(a) receptor activity and whether upregulation induced by cholesterol loading requires new protein synthesis. Furthermore, we explored several key properties of ligands that are needed for recognition by the foam cell-receptor activity. Our data show that the Lp(a)/ apo(a) receptor activity on cholesterol-loaded macrophages is trypsin sensitive, indicating that a cell-surface protein is involved and that the upregulation by cholesterol loading requires new protein synthesis. The ligand studies revealed that the foam cell receptor can recognize Lp(a) containing both small and large isoforms of apo(a). Moreover, whereas certain specific domains of apo(a) (eg, "protease" domain, kringle 5 [K5], K4 37 , and arginine-glycine-aspartic acid [RGD] site) and sialic acid residues appear not to be involved in this interaction, secondary and tertiary structural features of apo(a) are necessary for interaction with the upregu-lated receptor activity on foam cells. Remarkably, these structural features of apo(a) that are recognized by the foam cell receptor activity are distinct from those of plasminogen even though apo(a) and plasminogen are 80% homologous.
Methods Materials
Tissue culture media and reagents were obtained from GIBCO Laboratories, and fetal calf serum was purchased from Hyclone Laboratories. Lipoprotein-deficient serum (LPDS) was prepared from fetal calf serum by preparative ultracentrifugation (d, 1.21 g/mL). 17 Clostridium perfringens neuraminidase, type X-A, attached to agarose beads was from Sigma Chemical Co. Organic solvents were purchased from Fisher Scientific Co. All other reagents and chemicals were from Sigma.
Cells
All cells were maintained in a 37°C tissue culture incubator with a 5% CO 2 atmosphere in Dulbecco's modified Eagle's medium (DMEM) with penicillin (100 U/mL), streptomycin (100 /xg/mL), and freshly added glutamine (2 mmol/L). Resident mouse peritoneal macrophages from female ICR mice (20 to 25 g) were plated in DMEM/10% (vol/vol) fetal calf serum. 18 After 1 hour for adherence, the cells were washed twice with phosphate-buffered saline (PBS) and then, unless otherwise indicated, preincubated for 2 to 4 days in DMEM/ 10% LPDS alone or containing 25 ng acetyl-LDL/mL. Fresh medium was added to the cells each day. In certain experiments, the acetyl-LDL was removed the night before the 125 I-r-apo(a) degradation assay and substituted with lipoprotein-free cholesterol. This procedure was done because we were initially concerned that some of the 125 I-r-apo(a) interaction with foam cells might be due to binding of the ligand to residual acetyl-LDL on the cell surface (cf Reference 19) . Subsequent experiments indicated, however, that this type of interaction accounted for <10% of 125 I-r-apo(a) degradation by foam cells (P.J.S. and I.T., unpublished data).
Lipoproteins and Apoprotein(a)
Lp(a) with a total protein mass of 918 kD, obtained from the plasma of two subjects with a fast apo(a) polymorph, was purified by lysine-Sepharose affinity chromatography and cesium chloride gradient centrifugation as described in detail by Snyder et al.
14 Lp(a) containing a slow ("S") isoform of apo(a), with a total protein mass of 1246 kD, was isolated from the plasma of a subject with two isoforms of apo(a) by the procedure of Fless and Snyder, 20 which is slightly modified from the method referenced above. The lipoproteins isolated by ultracentrifugation at d=1.21 g/mL were dialyzed against 33 mmol/L phosphate, 1 mmol/L benzamidine, 0.01% Na 2 EDTA, and 0.01% NaN 3 , pH 7.4, and applied to a lysine-Sepharose column (20x2.5 cm) that was equilibrated in the same buffer. The Lp(a) was eluted from the column with a 200-mL gradient of 0 to 100 mmol/L fra/w-4-(aminomethyl)cyclohexanecarboxylic acid. Consecutive 40-mL fractions were collected, made to 7.5% (wt/vol) with solid CsCl, and centrifuged for 20 hours at 49 000 rpm at 20°C in a 50.2-Ti rotor with quick-seal tubes to establish a density gradient. Lp(a) with the slow apo(a) isoform floated at d= 1.087 g/mL, whereas Lp(a) with a fast apo(a) isoform floated at d= 1.054 g/mL. The slow Lp(a), in 0.15 mol/L NaCI, pH 7.4, containing 0.01% Na 2 EDTA and 0.01% NaN 3 , was filter sterilized (0.45 ^m) and stored in sterile plastic vials filled to allow no air space. Storage was at room temperature, in the dark, because of the tendency of slow Lp(a) to form a gel by self-association in the cold. To further ensure against aggregation, the slow Lp(a) was filtered after 125 I labeling (see below) through a 0.22 -/un low-proteinbinding membrane before use in the experiments; analysis of the prefilter and postfilter l25 I-lipoprotein concentrations indicated no significant loss during filtration. Rhesus Lp(a) was isolated from plasma by sequential flotation between rf=1.045 and <f=1.070 g/mL, followed by fast-performance liquid chromatography on a Mono-Q column as previously described.
21
LDL (d, 1.020 to 1.063 g/mL) from fresh human plasma was isolated by preparative ultracentrifugation. 17 Acetyl-LDL was prepared by reacting LDL with acetic anhydride as described by Basu et al. 22 The lipoproteins were labeled with 125 I (Dupont-New England Nuclear, carrier free) by the iodine monochloride method. 16 -23 r-Apo(a) (cf Reference 24), generously provided by Dr Dan L. Eaton of Genentech, was iodinated by the Iodo-bead method (Pierce Chemical Co).
125
I-labeled lipoproteins and r-apo(a) were at least 95% trichloroacetic acid precipitable, had a specific activity of 200 to 600 cpm/ng, and were used within 1 week of the labeling procedure.
Elastase Degradation Products of Plasminogen
Glutamate (Glu)-plasminogen was isolated from the fresh plasma of two subjects, whose Lp(a) level was <2 mg Lp(a) protein/mL, by lysine-Sepharose chromatography in the presence of 1 mmol/L benzamidine and 0.01% NaN 3 . The bound plasminogen was eluted from the column with a 0 to 20 mmol/L e-aminocaproic acid gradient and was further purified from Lp(a) by adjustment of consecutive 40-mL fractions to 7.5% (wt/vol) with solid CsCl and centrifugation of the plasminogen in a 50.2-Ti rotor at 49 000 rpm at 20°C for 20 hours. The floating Lp(a) was discarded, and plasminogen was recovered from the tube bottom. Forms 1 and 2 of Glu-plasminogen were pooled after sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 8% to 25% Phast gels and showed only single bands before and after reduction with 5% 2-mercaptoethanol. Digestion of Glu-plasminogen with porcine elastase was performed according to the method of Sottrup-Jensen et al 25 as described by Miles and Plow. The purity of the three domains was judged to be >95% on the basis of SDS-PAGE using 8% to 25% Phast gels.
Modifications of r-Apo(a)
Desialylation of 125 I-r-apo(a) was performed as follows: 130 fig of 125 I-r-apo(a) in 100 mmol/L sodium acetate (pH 6.5) was incubated at 37°C with 0.05 U of C perfringens neuraminidase (attached to agarose beads) for 18 hours with constant shaking. At the end of the incubation period, the agarose-attached neuraminidase was removed by low-speed centrifugation. SDS-PAGE (3% to 12.5% gradient) indicated that this treatment did not result in proteolytic degradation of the 125 I-rapo(a). The actual amount of sialic acid released after neuraminidase treatment was 85% to 95% as determined by the method of Warren. 27 For one experiment (see "Discussion"), a 0.75-mg aliquot of neuraminidase-treated l25 I-rapo(a) was incubated with 30 raU of endo-oAf-acetylgalactosaminidase (Streptococcuspneumoniae) and 20 U of peptide-N-glycosidase F (Flavobacterium meningosepticum) for 18 hours at 24°C; both enzymes were purchased from Oxford GlycoSystems, Inc.
125 I-r-apo(a) was denatured, reduced, and carboxymethylated according to Li et al. 28 Briefly, !25 I-rapo(a) (150 fig) in 0.5 mol/L Tris-HCl, pH 8.0, was denatured by the addition of 6 mol/L guanidine-HCl and 50 mmol/L dithiothreitol. After incubation for 1 hour at 25°C under a nitrogen atmosphere, iodoacetic acid was added to a final concentration of 150 mmol/L, and the reactants were removed by dialysis. Authenticity of 125 I-r-apo(a) reduction and denaturation was confirmed by SDS-PAGE.
Antibodies
Polyclonal IgG specific to the apo(a) moiety of human Lp(a) but nonreactive to plasminogen was prepared from goat antihuman Lp(a) serum that was passed sequentially over LDL, plasminogen, and Lp(a)-Sepharose 4B columns. The antibodies bound to the Lp(a)-Sepharose column were eluted with 0.1 mol/L glycine, pH 2.5, and were titrated immediately back to pH 7.4 with 1 mol/L tris(hydroxymethyl)aminomethane (Tris). The specificity of the antibody preparation was verified by Western blot and enzyme-linked immunosorbent assay. Rat anti-murine Fc--y 2 j receptor antibody, 2.4 G 2 (isotype 2B), was obtained from Pharmingen, and purified monomeric murine IgG2A was from Chemicon International, Inc.
I-Lp(a)/Apo(a) Degradation Assay
Total cellular degradation of 125 I-labeled ligands was assayed as described by Goldstein et al. 23 Cell monolayers were washed twice with PBS and once with DMEM/0.2% fatty acid-free bovine serum albumin (BSA) and then incubated with DMEM/0.2% BSA containing the indicated concentrations of 125 I-labeled Lp(a) or r-apo(a). After a 3-to 5-hour incubation at 37°C, the amount of 125 I-labeled trichloroacetic acid-soluble material formed by the cells and excreted into the medium was assayed. 23 Cell monolayers were then washed and dissolved with 0.1N NaOH, and the cellular DNA content was determined by the fluorometric method of Labarca and Paigen. 29 The data are expressed as picomoles of 
Statistics
Unless indicated otherwise, results are given as mean±SEM (n=3). Absent error bars signify SEM values smaller than the graphics symbols.
Results

Trypsin and Cycloheximide Sensitivity of the Inducible Foam Cell Apo(a) Receptor Activity
To determine whether a cell-surface protein was necessary for the foam cell Lp(a)/apo(a) receptor activity, receptor activity was assayed in unloaded (control) macrophages, foam cells, and trypsin-treated foam cells. The foam cell receptor activity described here recognizes the apo(a) moiety of Lp(a), 16 so ligand degradation was assayed by use of 125 I-labeled r-apo(a). The trypsin-treated foam cells appeared similar to the untreated foam cells by phase microscopy and excluded trypan blue. The data in Fig 1 show that foam cells degraded about fourfold more 125 I-r-apo(a) than control macrophages, consistent with our previous findings. 16 Trypsin-treated foam cells, however, degraded l25 I-r-apo(a) about threefold less than the untreated foam cells and only slightly more than control macrophages. Thus, exposure of foam cell surface proteins to a protease markedly diminishes the ability of these cells to degrade l25 I-r-apo(a), indicating that a cell-surface protein, most likely the receptor molecule itself, is necessary for the internalization and degradation of this ligand. To determine whether the upregulation of the apo(a) receptor activity that occurs with macrophage cholesterol loading requires new protein synthesis, l25 I-rapo(a) degradation was compared in unloaded (control) macrophages, cholesterol-loaded macrophages (foam cells), and macrophages that were loaded with cholesterol in the presence of the protein synthesis inhibitor cycloheximide (Fig 2A) . Note that cycloheximide does not block the ability of acetyl-LDL to load macrophages with cholesterol. 30 The data in Fig 2A show that inclusion of cycloheximide during the cholesterol loading period almost totally blocked the upregulation of receptor activity. In contrast to these data, experiments using 125 I-acetyl-LDL as the ligand (Fig 2B) showed that cholesterol loading did not lead to upregulation of the macrophage scavenger receptor (cf Reference 16), and foam cell scavenger receptor activity was not blocked by cycloheximide. Thus, the upregulation of apo(a) receptor activity on macrophages that occurs with cholesterol loading requires new protein synthesis.
The data in Fig 2A demonstrate another new point about the induction of the foam cell apo(a) receptor activity. Our previous studies used macrophages that had been subjected to relatively prolonged incubation periods (ie, 2 to 4 days) with lipoproteins or cholesterol. 16 In the experiment in Fig 2A, however, macrophages were incubated with acetyl-LDL for only 4.5 hours. The data show that even after a relatively short period of cholesterol loading, apo(a) receptor activity was upregulated more than fourfold. 125 l-acetyl-LDL, and total 125 l-ligand degradation was assayed. Cycloheximide (2 jimol/L) was added during the degradation to those cells that received cycloheximide during the preincubation period.
Degradation of Different Forms of Lp(a) by Foam Cells
Lp(a) is found to have a high degree of size heterogeneity, which is dependent on the number of repeating K4 2 units in the apo(a) moiety of Lp(a).
1231 Our previous work examined Lp(a) with only the smaller, more abundant isoforms of apo(a) (ie, fast ["F"] and "B"). 16 To determine whether the foam cell receptor activity recognized Lp(a) with a larger isoform of apo(a), the degradation by foam cells of Lp(a) containing the small, fast form of apo(a) was compared with the degradation of Lp(a) containing a large, slow form. The data in Fig 3 show that Lp(a) with the larger, slow apo(a) was degraded by foam cells even somewhat better than Lp(a) with the smaller, fast apo(a). Thus, the foam cell Lp(a) receptor activity recognizes Lp(a) containing both small and large isoforms of apo(a).
Lp(a) is also found in rhesus monkeys, although the apo(a) moiety of this Lp(a) differs in several respects from human apo(a), including an inactive lysine-binding domain at K4 37 and a modification of the RGD peptide sequence at K4 35 of human apo(a). 21 - 32 The data in Fig 3 show that foam cells degraded rhesus monkey Lp(a) to the same degree as human (fast isoform) Lp(a). Thus, neither an active K4 37 lysine-binding domain nor an intact K4 35 RGD sequence appears to be necessary for interaction with the foam cell Lp(a) receptor activity.
Ligand Competition and Antibody Studies
Since apo(a) shares 80% homology with plasminogen, we sought to determine whether the foam cell Lp(a)/apo(a) receptor activity recognized certain structural features of individual plasminogen domains. Although holoplasminogen does not appear to interact with the receptor activity, 16 it was possible that certain apo(a)-like regions of plasminogen, separate from the conformational constraints of the whole molecule, could be recognized by the foam cell receptor. Thus, individual peptide segments of plasminogen, generated by elastase digestion, 2526 were tested for their ability to competitively inhibit 125 I-r-apo(a) degradation by foam cells. These elastase degradation products (EDPs) in- elude three sequences: EDP I, containing kringles 1, 2, and 3 [which are not found in apo(a)]; EDP II, containing kringle 4 (specifically K4 37 ); and EDP III, containing both kringle 5 and the protease domain. 26 Fragments EDP II and EDP III inhibit the binding of 125 I-plasminogen to U937 cells. 21 The data in Fig 4A show, as before, that cholesterol loading of macrophages caused upregulation of an apo(a) receptor activity, and degradation of 125 I-r-apo(a) by the cholesterol-loaded foam cells was markedly inhibited by excess unlabeled r-apo(a). In contrast, the same molar excess of each of the three elastase degradation products of plasminogen did not inhibit degradation of 125 I-r-apo(a) by the foam cells. 125 I-r-apo(a) degradation by foam cells was inhibited, however, by a polyclonal antibody that recognizes the apo(a) moiety of human Lp(a) but that does not cross-react with plasminogen (Fig 4B) . Thus, although apo(a) shares extensive homology with plasminogen, the foam cell apo(a) receptor does not recognize sequences in apo(a) that are common to plasminogen.
Effect of Apo(a) Desialylation and Reduction/Denaturation
Since apo(a) is a richly sialylated glycoprotein, 24 -33 it was necessary to determine whether the foam cell receptor activity was a lectin that recognized the sialic acid residues of apo(a). Therefore, an aliquot of 125 I-rapo(a) was treated with neuraminidase such that 85% to 95% of the sialic acid residues were removed. The data in Fig 5 show that neuraminidase-treated 125 I-rapo(a), like untreated l25 I-r-apo(a), was degraded quite well by foam cells but not by unloaded macrophages. In fact, total degradation of neuraminidase-treated 125 I-rapo(a) by foam cells was =1.5 -fold greater than that of untreated 125 I-r-apo(a). When the "specific" component of this value was determined by competition with excess unlabeled native r-apo(a), however, the resulting value was very similar to that of untreated 125 I-r-apo(a). Thus, although a portion of neuraminidase-treated 125 Ir-apo(a) may bind to other sites on foam cells in addition to the upregulated apo(a) receptor activity, the data indicate that the sialic residues of apo(a) are not necessary for interaction with the upregulated foam cell apo(a) receptor activity. In an additional experiment to test the possible role of other sugar moieties known to be present on apo(a), 3234 we followed the strategy of Hajjar and Reynolds. 35 These investigators demonstrated that a 250-fold molar excess of D-fucose or D-galactose inhibited the binding of Last, we sought to determine whether the interaction of the foam cell receptor activity with apo(a), which has multiple disulfide bonds, ylated, and this ligand was compared with native l25 I-rapo(a) for uptake and degradation by control and foam cell macrophages. The data in Fig 6 demonstrate two points: first, whereas the degradation of native 125 I-rapo(a) was increased by =450% in foam cells, the degradation of reduced and denatured 125 I-r-apo(a) was increased by only 28% in foam cells; second, the total amount of reduced and denatured 125 I-r-apo(a) degraded by the foam cells was approximately half that of native 125 I-r-apo(a). Thus, the foam cell receptor activity appears to recognize certain features in the secondary and/or tertiary structure of apo(a). The approximately 50% degradation observed with reduced and denatured 125 I-r-apo(a) may represent either residual recognition by the foam cell apo(a) receptor or recognition by another receptor activity, since, unlike native 125 I-r-apo(a), interaction with unloaded macrophages was almost as great as with foam cells.
Discussion
Many questions concerning the possible functional roles and mechanisms of Lp(a) in atherogenesis, 1 -2 inflammation, 36 and other areas currently remain unanswered. Since macrophages are prominent in both atherosclerotic and inflammatory lesions and since Lp(a) is colocalized with macrophage foam cells in atheromata," understanding the interaction of Lp(a) with macrophages may provide important insight into the pathophysiology and physiology of Lp(a). Our recent report of an Lp(a)/apo(a) receptor activity on macrophages that is upregulated by cholesterol loading 16 provided the first convincing evidence that macrophages are able to internalize and lysosomally degrade native Lp(a) and r-apo(a) in a regulated fashion. We now show that the receptor activity is sensitive to cell-surface proteolysis, that the cholesterol-induced upregulation is dependent on new protein synthesis, that foam cells can interact with different-size isoforms of Lp(a) as well as rhesus monkey Lp(a), and that the receptor activity recognizes certain structural features of apo(a) that are distinct from those of plasminogen even though the two proteins share 80% homology.
The most likely interpretation of the cell-surface proteolysis data is that the internalization and degradation of r-apo(a) by foam cells are mediated by a cell-surface receptor protein. Along these lines, we have prepared detergent-solubilized membrane proteins from foam cells, separated these proteins by native PAGE, and probed blots of these native gels with I25 I-r-apo(a). These ligand blots have revealed a single band that binds 125 I-r-apo(a) with many of the characteristics demonstrated for 1Z5 I-r-apo(a) interaction with intact foam cells, including calcium dependence, 16 trypsin sensitivity, and displaceability by excess unlabeled r-apo(a) (G.A. Keesler, Y. Li, D.L. Eaton, and I. Tabas, unpublished data). Protein purification and inhibitory antibody generation will be needed, however, before we can determine whether this band includes a protein that is, in fact, responsible for the foam cell Lp(a)/apo(a) receptor activity. Nonetheless, our present data have revealed two important characteristics of the foam cell receptor activity in addition to its sensitivity to cellsurface proteolysis: induction can occur after a relatively short period of cholesterol loading (ie, 4.5 hours versus 2 to 4 days in our previous study 16 ), and cholesterol-mediated induction requires new protein synthesis (Fig 2) . The requirement for new protein synthesis indicates that cholesterol 16 or an intracellular cholesterol metabolite (eg, an oxysterol 37 ), rather than simply causing a preexisting cell-surface protein to become "exposed," leads to the induction of either the Lp(a)/ apo(a) receptor molecule itself or a protein that is critical for receptor function.
The ligand studies in this report have also revealed some important properties of the foam cell Lp(a)/ apo(a) receptor activity. First, whereas our previous report used Lp(a) containing only small isoforms of apo(a) (ie, "F" and "B"), 16 the data in Fig 3 reveal that foam cells can also internalize and degrade Lp(a) containing a very large ("S") isoform of apo(a). In fact, the data show that the Lp(a) with the large isoform was internalized and degraded to an even greater extent (=1.6-fold, P<.002) by foam cells than Lp(a) with the small isoform. The reason for this difference is not known. If the concentration of 125 I-Lp(a) used in this experiment (25 nmol/L) was below receptor saturation, one interpretation of these data could be that the Lp(a) with the large isoform had a greater affinity for the receptor than Lp(a) with the small isoform [eg, by virtue of a greater number of receptor-binding sites per Lp(a) particle resulting from the extra copies of K4 2 on the large isoform of apo(a)] (cf Reference 38 and below). Alternatively, if 25 nmol/L Lp(a) was above receptor saturation, this might mean that additional receptor sites were available for the large isoform of apo(a) [eg, by recognition of the large isoform apo(a) by a subpopulation of cell-surface apo(a) receptors that do not readily interact with the small isoform]. Since the fold increase in 125 I-Lp(a) degradation by foam cells versus control macrophages in this experiment was even greater for Lp(a) with the large isoform (approximately eightfold) than for Lp(a) with the small isoform (approximately fourfold) (data not shown), these putative additional receptor sites would also be subject to cholesterol-induced upregulation. We attempted 4°C binding studies to distinguish between these and other possibilities; however, despite the high degree of specificity of the receptor activity as demonstrated by the 37°C 125 I-r-apo(a) degradation data (eg , Fig 4) , The data in Fig 3 also show that rhesus monkey Lp(a) is internalized and degraded by foam cells to a similar degree as human Lp(a). This finding indicates that certain features on human apo(a) that are altered or absent on rhesus monkey apo(a) are not necessary for recognition by the foam cell receptor. These features include a cysteine-to-histidine substitution in the catalytic triad of the protease region of simian apo(a), absence of the K5-like domain, absence of a key lysinebinding aspartic acid residue in all K4 structures except K4 37 , absence of a key tryptophan residue involved in lysine binding in K4 37 , and alteration of an RGD cell-surface integrin binding sequence in K4 35 . 32 The alterations in the lysine-binding domains of simian apo(a) are particularly important: these changes, especially those in K4 37 , are thought to be responsible for the decreased ability of monkey Lp(a) versus human Lp(a) to bind to lysine-Sepharose and U937 cells. 21 Thus, the fact that rhesus monkey Lp(a) interacts well with foam cells, together with our previous finding that the lysine analogue, e-aminocaproic acid, does not inhibit the interaction of human Lp(a) with foam cells, 16 indicates that interaction of apo(a) with the foam cell receptor does not involve the lysine-binding domains of apo(a).
Our ligand studies have also explored in detail the issue of whether the foam cell receptor activity recognizes a site on apo(a) that is in common with plasminogen, which shares 80% homology with apo(a). 38 Our previous publication mentioned that plasminogen did not compete for 125 I-Lp(a) binding to foam cells. 16 This experiment, however, used a 4°C binding assay, which we now know includes nonspecific interactions (G.A. Keesler, Y. Li, D.L. Eaton, and I. Tabas, unpublished data). Furthermore, as mentioned in the "Results," the conformational constraints of the intact plasminogen molecule may have masked its ability to competitively inhibit l25 I-r-apo(a) uptake by foam cells even if there were a plasminogen-like region in apo(a) that was important in receptor binding. Thus, for these reasons, together with the remarkably high degree of homology between apo(a) and plasminogen, 38 we thought that this issue needed to be investigated further. In the present report, we present several pieces of evidence that, when viewed together, strongly indicate that the receptor recognition site or sites on apo(a) include features of the molecule that are different from those shared with plasminogen. First, simian Lp(a), which lacks both the K5 domain of plasminogen and important structural features of the K4 domain of plasminogen (see above), ported in part by a National Research Service Award from the NIH. Dr Skiba is supported in part by a Postdoctoral Atherosclerosis Training Grant Award from the NIH. The authors wish to thank Dr Dan L. Eaton (Genentech) for providing the recombinant apo(a) and Dr Angelo M. Scanu (University of Chicago) for providing rhesus monkey plasma.
